TABLE 3.
Endpoint | Included variables | Hazard ratio (p-value) |
|
Model: Dtot | Model: Dcontra | ||
XERG≥2 | Mean parotid dose (Dtot or Dcontra) | 0.98 (<0.01) | 0.997 (0.68) |
Dipsi | – | 0.99 (<0.01) | |
Tumor location; reference = oral cavity | |||
Oropharynx | 1.07 (0.67) | 1.07 (0.67) | |
Other | 0.57 (<0.01) | 0.58 (<0.01) | |
N stage; reference = 2c | |||
0 | 0.58 (<0.01) | 0.62 (0.020) | |
1 | 0.57 (0.014) | 0.61 (0.042) | |
2a/b | 0.69 (0.027) | 0.73 (0.080) | |
3 | 0.31 (0.052) | 0.33 (0.067) | |
Concomitant chemotherapy; reference = no | |||
Cisplatin | 2.02 (<0.01) | 1.98 (<0.01) | |
Erbitux | 1.46 (0.011) | 1.42 (0.019) | |
Age | 1.02 (<0.01) | 1.02 (<0.01) | |
C-statistic (SE) | 0.60 (0.057) | 0.60 (0.057) |
The bootstrap-validation C-statistic is listed below the included variables.